HSP90AB1 and breast carcinoma: Previous studies have shown that high expression levels of HSP90 (HSP90α and HSP90β) increase the likelihood of recurrence and distant metastases in triple negative and ER+/HER2-breast cancer, and are associated with higher mortality [69].